Bircan, K. Et Al. 1990. Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH). Hacettepe Medical Journal , vol.23, no.1 , 75-80.

Bircan, K., ÖZEN, H., Ergen, A., Basar, I., ÖZGÜR, S. F., Ilker, Y., ... KARAAĞAOĞLU, A. E.(1990). Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH). Hacettepe Medical Journal , vol.23, no.1, 75-80.

Bircan, K. Et Al. "Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)," Hacettepe Medical Journal , vol.23, no.1, 75-80, 1990

Bircan, K. Et Al. "Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)." Hacettepe Medical Journal , vol.23, no.1, pp.75-80, 1990

Bircan, K. Et Al. (1990) . "Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)." Hacettepe Medical Journal , vol.23, no.1, pp.75-80.

@article{article, author={K. Bircan Et Al. }, title={Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)}, journal={Hacettepe Medical Journal}, year=1990, pages={75-80} }